title: Effective squaric acid dibutylester immunotherapy is associated with a reduction of skin infiltrating T-helper (Th)1 and Th17 cells in alopecia areata patients.
authors.affiliation: Laboratory of Experimental Immunology, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.
authors.forename: Simona
authors.initials: S
authors.lastname: Avitabile
authors.forename: Donatella
authors.initials: D
authors.lastname: Sordi
authors.forename: Simone
authors.initials: S
authors.lastname: Garcovich
authors.forename: Laura
authors.initials: L
authors.lastname: Colonna
authors.forename: Anastasia
authors.initials: A
authors.lastname: De Luca
authors.forename: Francesca
authors.initials: F
authors.lastname: Nasorri
authors.forename: Cinzia
authors.initials: C
authors.lastname: Mazzanti
authors.forename: Andrea
authors.initials: A
authors.lastname: Cavani
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology / Q000627:therapeutic use*; D000506:Alopecia Areata / Q000276:immunology / Q000628:therapy*; D003503:Cyclobutanes / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy; D011446:Prospective Studies; D018417:Th1 Cells; D058504:Th17 Cells
chemical_list: D000276:Adjuvants, Immunologic; D003503:Cyclobutanes; C020637:squaric acid dibutyl ester